Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




A Chemical in Red Wine, Fruits and Vegetables Stops Cancer

By Biotechdaily staff writers
Posted on 13 Nov 2007
A new study has found that very high doses of antioxidant polyphenols--commonly found in red wine, fruits, vegetables, and green tea--shut down cancerous tumors by cutting off the formation of new blood vessels needed for their growth. More...


Researchers at the University of Angers (France) investigated the effects of polyphenols on postischemic neovascularization. Rats treated with low doses of red wine polyphenolic compounds were submitted to femoral artery ligature on the left leg. The researchers found that at relatively low doses, polyphenols play a beneficial role for those with diseased hearts and circulatory systems by facilitating blood vessel growth. The amount of polyphenols necessary for this effect was found to be the equivalent of only one glass of red wine per day or simply sticking to a healthy diet of fruits and vegetables containing polyphenols.

However, according to the authors, the amount of polyphenols necessary to obtain an anti-cancer effect is the equivalent of drinking about a bottle of red wine each day. This amount of daily alcohol consumption obviously is unhealthy, but the researchers suggest that polyphenols extracted from plants or red wine could be converted into a pill form that is highly likely to be safe. Such a pill also would be relatively easy and inexpensive to create and deliver. The study was published in the November 2007 issue of The Federation of American Societies for Experimental Biology (FASEB) Journal.

"The use of plant polyphenols as therapeutic tools presents important advantages,” said lead author Daniel Henrion, Ph.D., "because they have a good safety profile, a low cost and they can be obtained everywhere on the planet.”

This study also adds to a growing body of research showing dose-dependent relationships for many types of commonly used compounds; for instance, research published in the October 2006 issue of The FASEB Journal showed that aspirin, through different mechanisms, also has a dose-dependent relationship for heart disease and cancer.


Related Links:
University of Angers

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.